Early life growth and hemostatic factors

American Journal of Epidemiology

Volumn 168, Issue 2, 2008, Pages 179-187

  Fraser, A ^a   Hughes, R ^a   McCarthy, A ^b   Tilling, K ^a   Davies, D ^c   Rumley, A ^d   Lowe, G D O ^d   Davey Smith, G ^a   Ben Shlomo, Y ^a  

^a UNIVERSITY OF BRISTOL   (United Kingdom)

^b HEALTH RESEARCH BOARD   (Ireland)

^c CARDIFF UNIVERSITY   (United Kingdom)

^d UNIVERSITY OF GLASGOW   (United Kingdom)

Author keywords

Factor VII; Factor VIII; Fibrin fibrinogen degradation products; Fibrinogen; Growth and development; Tissue plasminogen activator; Von Willebrand factor

Indexed keywords

D DIMER; FIBRINOGEN; VON WILLEBRAND FACTOR;

ADULT; ASSESSMENT METHOD; BIOLOGICAL DEVELOPMENT; GROWTH;

ADULT; ANTHROPOMETRIC PARAMETERS; ARTICLE; BIRTH LENGTH; BIRTH WEIGHT; CARDIOVASCULAR RISK; CONFIDENCE INTERVAL; FEMALE; HUMAN; INFECTION; LIVER DEVELOPMENT; MAJOR CLINICAL STUDY; MALE; PERINATAL PERIOD;

ADULT; ANTIGENS; BIRTH WEIGHT; BLOOD COAGULATION FACTORS; BODY HEIGHT; CHILD, PRESCHOOL; FACTOR VII; FACTOR VIII; FEMALE; FIBRINOGEN; FOLLOW-UP STUDIES; GROWTH; HUMANS; INFANT; INFANT, NEWBORN; LINEAR MODELS; MALE; MULTIVARIATE ANALYSIS; RANDOMIZED CONTROLLED TRIALS AS TOPIC; TISSUE PLASMINOGEN ACTIVATOR; VON WILLEBRAND FACTOR;

EID: 46749158319     PISSN: 00029262     EISSN: 14766256     Source Type: Journal    
DOI: 10.1093/aje/kwn106     Document Type: Article

References (33)

1. Stein CE, Fall CH, Kumaran K, et al. Fetal growth and coronary heart disease in south India. Lancet 1996;348:1269-73.
2. Rich-Edwards JW, Stampfer MJ, Manson JE, et al. Birth weight and risk of cardiovascular disease in a cohort of women followed up since 1976. BMJ 1997;315:396-400.
3. Frankel S, Elwood P, Davey Smith G, et al. Birthweight, body-mass index in middle age, and incident coronary heart disease. Lancet 1996;348:1478-80.
4. Eriksson JG, Forsen T, Tuomilehto J, et al. Early growth and coronary heart disease in later life: longitudinal study. BMJ 2001;322:949-53.
5. Forsen T, Eriksson JG, Tuomilehto J, et al. Growth in utero and during childhood among women who develop coronary heart disease: longitudinal study. BMJ 1999;319:1403-7.
6. Singhal A, Lucas A. Early origins of cardiovascular disease: is there a unifying hypothesis? Lancet 2004;363:1642-5.
7. Barker DJ, Osmond C, Forsen TJ, et al. Trajectories of growth among children who have coronary events as adults. N Engl J Med 2005;353:1802-9.
8. Latini G, De Mitri B, Del Vecchio A, et al. Foetal growth of kidneys, liver and spleen in intrauterine growth restriction: "programming" causing "metabolic syndrome" in adult age. Acta Paediatr 2004;93:1635-9.
9. Burns SP, Desai M, Cohen RD, et al. Gluconeogenesis, glucose handling, and structural changes in livers of the adult offspring of rats partially deprived of protein during pregnancy and lactation. J Clin Invest 1997;100:1768-74.
10. Desai M, Crowther NJ, Ozanne SE, et al. Adult glucose and lipid metabolism may be programmed during fetal life. Biochem Soc Trans 1995;23:331-5.
11. Hales CN, Desai M, Ozanne SE, et al. Fishing in the stream of diabetes: from measuring insulin to the control of fetal organogenesis. Biochem Soc Trans 1996;24:341-50.
12. Andersen AMN, Osler M. Birth dimensions, parental mortality, and mortality in early adult age: a cohort study of Danish men born in 1953. Int J Epidemiol 2004;33:92-9.
13. Fraser A, Ebrahim S, Davey Smith G, et al. The association between birthweight and adult markers of liver damage and function. Paediatr Perinat Epidemiol 2008;22:12-21.
14. Davies AA, Davey Smith G, Ben-Shlomo Y, et al. Low birth weight is associated with higher adult total cholesterol concentration in men: findings from an occupational cohort of 25,843 employees. Circulation 2004;110:1258-62.
15. Martyn CN, Meade TW, Stirling Y, et al. Plasma concentrations of fibrinogen and factor VII in adult life and their relation to intra-uterine growth. Br J Haematol 1995;89:142-6.
16. Barker DJ, Meade TW, Fall CH, et al. Relation of fetal and infant growth to plasma fibrinogen and factor VII concentrations in adult life. BMJ 1992;304:148-52.
17. Fall CH, Osmond C, Barker DJ, et al. Fetal and infant growth and cardiovascular risk factors in women. BMJ 1995;310:428-32.
18. Roseboom TJ, van der Meulen JHP, Ravelli ACJ, et al. Plasma fibrinogen and factor VII concentrations in adults after prenatal exposure to famine. Br J Haematol 2000;111:112-17.
19. Leger J, Levy-Marchal C, Bloch J, et al. Reduced final height and indications for insulin resistance in 20 year olds born small for gestational age: regional cohort study. BMJ 1997;315:341-7.
20. Fraser A, Ebrahim S, Davey Smith G, et al. The associations between height components (leg and trunk length) and adult levels of liver enzymes. J Epidemiol Community Health 2008;62:48-53.
21. Barker DJ. Fetal programming of coronary heart disease. Trends Endocrinol Metab 2002;13:364-8.
22. Lowe GD. Circulating inflammatory markers and risks of cardiovascular and non-cardiovascular disease. J Thromb Haemost 2005;3:1618-27.
23. Ben-Shlomo Y, Holly J, McCarthy A, et al. An investigation of fetal, postnatal and childhood growth with insulin-like growth factor I and binding protein 3 in adulthood. Clin Endocrinol (Oxf) 2003;59:366-73.
24. Yarnell JW, Patterson CC, Sweetnam PM, et al. Haemostatic/inflammatory markers predict 10-year risk of IHD at least as well as lipids: the Caerphilly collaborative studies. Eur Heart J 2004;25:1049-56.
25. Gunnell D, Whitley E, Upton MN, et al. Associations of height, leg length, and lung function with cardiovascular risk factors in the Midspan Family Study. J Epidemiol Community Health 2003;57:141-6.
26. Harder T, Rodekamp E, Schellong K, et al. Birth weight and subsequent risk of type 2 diabetes: a meta-analysis. Am J Epidemiol 2007;165:849-57.
27. Wannamethee SG, Lowe GD, Shaper AG, et al. Insulin resistance, haemostatic and inflammatory markers and coronary heart disease risk factors in type 2 diabetic men with and without coronary heart disease. Diabetologia 2004;47:1557-65.
28. Matthews DR, Hosker JP, Rudenski AS, et al. Homeostasis model assessment: insulin resistance and beta-cell function from fasting plasma glucose and insulin concentrations in man. Diabetologia 1985;28:412-19.
29. McCarthy A, Hughes R, Tilling K, et al. Birth weight, postnatal, infant and childhood growth and obesity in young adulthood: evidence from the Barry Caerphilly Growth (BCG) study. Am J Clin Nutr 2007;86:907-13.
30. Stephensen CB. Burden of infection on growth failure. J Nutr 1999;129(suppl):534S-8S.
31. Esmon CT. The interactions between inflammation and coagulation. Br J Haematol 2005;131:417-30.
32. Ben-Shlomo Y, Holly J, McCarthy A, et al. Prenatal and postnatal milk supplementation and adult insulin-like growth factor I: long-term follow-up of a randomized controlled trial. Cancer Epidemiol Biomarkers Prev 2005;14:1336-9.
33. Martin RM, McCarthy A, Davey Smith G, et al. Infant nutrition and blood pressure in early adulthood: the Barry Caerphilly Growth study. Am J Clin Nutr 2003;77:1489-97.